Articles about Product Safety

Inventiva (IVA) Q2 2026 Earnings Call Transcript ↗

Today 10:00 EDT

Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Seek Leadership in a Securities Fraud Lawsuit by November 3, 2026

Today 9:45 EDT

ReposiTrak (TRAK) Q4 2026 Earnings Call Transcript ↗

Today 3:13 EDT

Kaplan Fox & Kilsheimer LLP Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to the Lead Plaintiff Deadline on November 3, 2026

VivoSim Labs Inc. (NASDAQ: VIVS) Targets the Multibillion-Dollar Cost of Failed Drugs

September 28, 2026

Via AB Newswire

September 28, 2026

ReposiTrak Q4 Earnings Call Highlights ↗

September 28, 2026

Robbins LLP is Investigating Allegations that Replimune Group, Inc. Misled Investors Regarding the Efficacy and Viability of its Lead Product Candidate RP1

RIXA Recovery and Performance Announces Grand Opening of New Perrysburg Location

September 28, 2026

Via Press Advantage

September 28, 2026

Via Newsfile

DreaMed Receives FDA Clearance for MODI, Bringing Automated Insulin Dose Recommendations to People with Type 2 Diabetes Using Injections

September 28, 2026

Via Newsfile

Kaplan Fox Deadline Alert: Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors Have Until November 2, 2026 to Seek a Lead Plaintiff Role

September 28, 2026

Xenon Files Azetukalner NDA as It Pauses Psychiatry Trials for Tolerability Review ↗

September 27, 2026

Here's Exactly Why Wall Street Thinks Argenx Stock Could Soar 23% Over the Next 12 Months ↗

BeautySnob Launches Market-Specific Ingredient Safety Scores for Beauty Products

September 27, 2026

Via Press Release Distribution Service

September 26, 2026

BridgeBio Pharma Eyes Four Global Launches by 2027 as Attruby Nears Blockbuster Status ↗

September 26, 2026

Kaplan Fox & Kilsheimer LLP Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before November 3, 2026

September 25, 2026

Woman-Owned NuYOU360 Prices FDA Cleared Red Light Therapy Masks From $289, Built on the Founder’s Own Decade of Daily Use

September 25, 2026

Via AB Newswire

Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026

September 25, 2026

TechMediaBreaks – SS Innovations International Inc. (NASDAQ: SSII) Eyes Growing Opportunity for Surgical Robotics

September 25, 2026

Via Investor Brand Network

Kaplan Fox Reminds Investors of Medline Inc. (NASDAQ: MDLN) of an Ongoing Investigation into Potential Securities Law Violations

September 25, 2026

Kaplan Fox Announces an Investigation of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) on Behalf of Long-Term Investors

Cheelcare Announces First Quarter Fiscal 2027 Financial Results

September 25, 2026

Via Newsfile

September 25, 2026

United Therapeutics Maps 14 Launches, Fibrosis Growth and Xenokidney Ambitions ↗

September 25, 2026

Here's Why Grail Stock Surged 55% This Week ↗

September 25, 2026

Was Hanuman Really His Name? ↗

September 25, 2026

Via Talk Markets

Linda Jensen Went From Wanting to Be Invisible to Helping Others Find Clarity

September 25, 2026

Via 24-7 Press Release

2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds

September 25, 2026

Via StockStory

Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines? ↗

September 24, 2026

Kaplan Fox & Kilsheimer LLP Reminds Investors of a Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX) and Lead Plaintiff Deadline on November 3, 2026

September 24, 2026

Compass Pathways Targets Q4 COMP360 NDA Completion, Eyes 2027 Launch ↗

September 24, 2026